• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白在儿科疾病中的作用。

The role of fecal calprotectin in pediatric disease.

作者信息

Jeong Su Jin

机构信息

Department of Pediatrics, Bundang CHA Medical Center, CHA University School of Medicine, Seongnam, Korea.

出版信息

Korean J Pediatr. 2019 Aug;62(8):287-291. doi: 10.3345/kjp.2019.00059. Epub 2019 Mar 28.

DOI:10.3345/kjp.2019.00059
PMID:30999729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6702112/
Abstract

Fecal calprotectin (FC) is a calcium- and zinc-binding protein of the S100 family, mainly expressed by neutrophils and released during inflammation. FC became an increasingly useful tool both for gastroenterologists and for general practitioners for distinguishing inflammatory bowel disease (IBD) from irritable bowel syndrome. Increasing evidences support the use of this biomarker for diagnosis, follow-up and evaluation of response to therapy of several pediatric gastrointestinal diseases, ranging from IBD to nonspecific colitis and necrotizing enterocolitis. This article summarizes the current literature on the use of FC in clinical practice.

摘要

粪便钙卫蛋白(FC)是S100家族的一种钙结合和锌结合蛋白,主要由中性粒细胞表达并在炎症期间释放。FC对于胃肠病学家和全科医生而言,已成为区分炎症性肠病(IBD)和肠易激综合征越来越有用的工具。越来越多的证据支持将这种生物标志物用于多种儿科胃肠疾病的诊断、随访及治疗反应评估,范围从IBD到非特异性结肠炎和坏死性小肠结肠炎。本文总结了目前关于FC在临床实践中应用的文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6702112/84b79dd8ac02/kjp-2019-00059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6702112/84b79dd8ac02/kjp-2019-00059f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c8e/6702112/84b79dd8ac02/kjp-2019-00059f1.jpg

相似文献

1
The role of fecal calprotectin in pediatric disease.粪便钙卫蛋白在儿科疾病中的作用。
Korean J Pediatr. 2019 Aug;62(8):287-291. doi: 10.3345/kjp.2019.00059. Epub 2019 Mar 28.
2
Usefulness of fecal calprotectin determination in pediatric intestinal diseases.粪便钙卫蛋白测定在儿科肠道疾病中的应用价值
Minerva Pediatr. 2016 Dec;68(6):478-486. Epub 2016 Sep 21.
3
Fecal calprotectin: beyond intestinal organic diseases.粪便钙卫蛋白:超越肠道器质性疾病。
Panminerva Med. 2018 Mar;60(1):29-34. doi: 10.23736/S0031-0808.18.03405-5. Epub 2018 Jan 25.
4
Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician.粪便钙卫蛋白的临床应用:基层医疗医生在炎症性肠病之外的潜在应用
Ann Gastroenterol. 2019 Sep-Oct;32(5):425-430. doi: 10.20524/aog.2019.0394. Epub 2019 Jun 20.
5
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.粪便钙卫蛋白是一种有效的诊断工具,可区分炎症性肠病和功能性肠病。
Scand J Gastroenterol. 2014 Dec;49(12):1419-24. doi: 10.3109/00365521.2014.934913. Epub 2014 Nov 5.
6
FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.重点:粪便钙卫蛋白在炎症性肠病中的应用研究前景。
World J Gastroenterol. 2016 Sep 28;22(36):8211-8. doi: 10.3748/wjg.v22.i36.8211.
7
FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.粪便钙卫蛋白:巴西胃肠道症状患者病因诊断的水平
Arq Gastroenterol. 2015 Jan-Mar;52(1):50-4. doi: 10.1590/S0004-28032015000100011.
8
From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.从基础到临床:粪便钙卫蛋白在炎症性肠病临床中的应用。
World J Gastroenterol. 2018 Sep 7;24(33):3681-3694. doi: 10.3748/wjg.v24.i33.3681.
9
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.粪便钙卫蛋白作为炎症性肠病肠道炎症生物标志物的作用。
Inflamm Bowel Dis. 2006 Jun;12(6):524-34. doi: 10.1097/00054725-200606000-00013.
10
[Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].[粪便钙卫蛋白:一种用于炎症性肠病的诊断工具]
Rev Med Suisse. 2012 Sep 5;8(352):1669-70, 1672-3.

引用本文的文献

1
Fecal calprotectin as a marker of intestinal inflammation in pediatric cystic fibrosis patients.粪便钙卫蛋白作为小儿囊性纤维化患者肠道炎症的标志物。
Eur J Pediatr. 2025 Sep 8;184(10):605. doi: 10.1007/s00431-025-06442-9.
2
Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons.粪便钙卫蛋白在儿童胃肠道疾病中的利弊
World J Clin Pediatr. 2024 Jun 9;13(2):93341. doi: 10.5409/wjcp.v13.i2.93341.
3
Exploring the Diagnostic Spectrum of Children with Raised Faecal Calprotectin Levels.探索粪便钙卫蛋白水平升高儿童的诊断范围

本文引用的文献

1
Elevated fecal calprotectin levels are associated with severity of atopic dermatitis in children.粪便钙卫蛋白水平升高与儿童特应性皮炎的严重程度相关。
Asian Pac J Allergy Immunol. 2018 Jun;36(2):82-87. doi: 10.12932/AP-100317-0044.
2
Delivery and feeding mode affects fecal calprotectin levels in infants <7months old.分娩和喂养方式会影响7个月以下婴儿的粪便钙卫蛋白水平。
Early Hum Dev. 2017 May;108:45-48. doi: 10.1016/j.earlhumdev.2017.03.014. Epub 2017 Apr 6.
3
Fecal calprotectin level in healthy children aged less than 4 years in South Korea.
Children (Basel). 2024 Apr 2;11(4):420. doi: 10.3390/children11040420.
4
Promoting early testing and appropriate referral to reduce diagnostic delay for children with suspected inflammatory bowel disease, a narrative review.促进早期检测和适当转诊以减少疑似炎症性肠病儿童的诊断延迟:一项叙述性综述
Transl Pediatr. 2023 Jul 31;12(7):1416-1430. doi: 10.21037/tp-23-35. Epub 2023 Jun 25.
5
Possible Correlation between Genotypes and Fecal Calprotectin in Children with Diarrhea.腹泻儿童基因型与粪便钙卫蛋白之间的可能关联
Iran J Parasitol. 2022 Oct-Dec;17(4):488-496. doi: 10.18502/ijpa.v17i4.11275.
6
Infantile Colic and the Subsequent Development of the Irritable Bowel Syndrome.婴儿腹绞痛与肠易激综合征的后续发展
J Neurogastroenterol Motil. 2022 Oct 30;28(4):618-629. doi: 10.5056/jnm21181.
7
Association of fecal calprotectin level with eosinophilic gastrointestinal disease in Iranian pediatrics.伊朗儿科患者粪便钙卫蛋白水平与嗜酸性胃肠道疾病的关联
Allergy Asthma Clin Immunol. 2022 Sep 30;18(1):86. doi: 10.1186/s13223-022-00728-5.
8
Potential Utility of Fecal Calprotectin in Discriminating Colorectal Polyps From Other Major Etiologies in Children Presenting With Isolated Hematochezia.粪便钙卫蛋白在鉴别儿童孤立性血便中大肠息肉与其他主要病因的潜在应用。
J Korean Med Sci. 2022 Mar 7;37(9):e72. doi: 10.3346/jkms.2022.37.e72.
9
Biomarkers in Glycogen Storage Diseases: An Update.糖原贮积病中的生物标志物:最新进展
Int J Mol Sci. 2021 Apr 22;22(9):4381. doi: 10.3390/ijms22094381.
10
Validation of the newly FDA-approved Buhlmann fCal Turbo assay for measurement of fecal calprotectin in a pediatric population.新获得美国食品药品监督管理局(FDA)批准的用于测量儿科人群粪便钙卫蛋白的Buhlmann fCal Turbo检测法的验证。
Pract Lab Med. 2020 Oct 17;22:e00178. doi: 10.1016/j.plabm.2020.e00178. eCollection 2020 Nov.
韩国4岁以下健康儿童的粪便钙卫蛋白水平
J Clin Lab Anal. 2017 Nov;31(6). doi: 10.1002/jcla.22113. Epub 2017 Jan 16.
4
Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.粪便生物标志物诊断检测症状性患者结直肠癌和腺瘤的准确性。
Aliment Pharmacol Ther. 2017 Jan;45(2):354-363. doi: 10.1111/apt.13865. Epub 2016 Dec 1.
5
Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease.粪便钙卫蛋白:影响其水平的因素及其作为克罗恩病发病风险替代标志物的潜在作用。
BMC Gastroenterol. 2016 Oct 7;16(1):126. doi: 10.1186/s12876-016-0535-z.
6
Usefulness of fecal calprotectin determination in pediatric intestinal diseases.粪便钙卫蛋白测定在儿科肠道疾病中的应用价值
Minerva Pediatr. 2016 Dec;68(6):478-486. Epub 2016 Sep 21.
7
High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6.2 月龄时粪便钙卫蛋白水平较高作为肠道炎症的标志物可预测 6 月龄时特应性皮炎和哮喘。
Clin Exp Allergy. 2015 May;45(5):928-939. doi: 10.1111/cea.12522.
8
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.粪便钙卫蛋白是一种有效的诊断工具,可区分炎症性肠病和功能性肠病。
Scand J Gastroenterol. 2014 Dec;49(12):1419-24. doi: 10.3109/00365521.2014.934913. Epub 2014 Nov 5.
9
Fecal calprotectin concentration in neonatal necrotizing enterocolitis.新生儿坏死性小肠结肠炎中粪便钙卫蛋白浓度
Korean J Pediatr. 2014 Aug;57(8):351-6. doi: 10.3345/kjp.2014.57.8.351. Epub 2014 Aug 25.
10
Relationship between gut microbiota and development of T cell associated disease.肠道微生物群与T细胞相关疾病发展之间的关系。
FEBS Lett. 2014 Nov 17;588(22):4195-206. doi: 10.1016/j.febslet.2014.03.019. Epub 2014 Mar 26.